As filed with the Securities and Exchange Commission on September 29, 2003.
Registration No. 333-
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form S-8
REGISTRATION STATEMENT
Under
THE SECURITIES ACT OF 1933
Abbott Laboratories
(Exact name of registrant as specified in its charter)
| Illinois (State or other jurisdiction of incorporation or organization) |
36-0698440 (I.R.S. Employer Identification No.) |
|
Abbott Laboratories 100 Abbott Park Road Abbott Park, Illinois (Address of Principal Executive Offices) |
60064-6400 (Zip Code) |
ABBOTT LABORATORIES AFFILIATE EMPLOYEE STOCK PURCHASE PLAN
(Full Title of the Plan)
Jose M. de Lasa
Abbott Laboratories
100 Abbott Park Road
Abbott Park, Illinois 60064-6400
(Name and address of agent for service)
Telephone number, including area code, of agent for service: (847) 937-5200
CALCULATION OF REGISTRATION FEE
| Title of Securities to be Registered |
Amount to be Registered(1) |
Proposed Maximum Offering Price Per Share(2) |
Proposed Maximum Aggregate Offering Price(2) |
Amount of Registration Fee |
||||
|---|---|---|---|---|---|---|---|---|
| Common shares (without par value) including Preferred Stock Purchase Rights | 2,000,000 | $42.425 | $84,850,000 | $6,865 | ||||
Part II. Information Required in the Registration Statement
Item 3. Incorporation of Documents by Reference
The contents of Abbott Laboratories Affiliate Employee Stock Purchase Plan Registration Statement on Form S-8 (File no. 333-75442) are incorporated herein by reference.
Item 5. Interest of Named Experts and Counsel
Jose M. de Lasa, Esq., Senior Vice President, Secretary and General Counsel of the Registrant, whose opinion is included herewith as Exhibit 5, beneficially owned as of September 22, 2003, approximately 144,204 Common Shares of the Registrant (this amount includes approximately 2,234 shares held for the benefit of Mr. de Lasa in the Abbott Laboratories Stock Retirement Trust pursuant to the Abbott Laboratories Stock Retirement Plan) and held options to acquire 701,636 Common Shares of which options to purchase 494,527 Common Shares are currently exercisable.
See Exhibit Index which is incorporated herein by reference.
S-1
The Registrant. Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in unincorporated Lake County, and State of Illinois, on September 29, 2003.
| ABBOTT LABORATORIES | |||
By: |
/s/ MILES D. WHITE Miles D. White, Chairman of the Board and Chief Executive Officer |
||
S-2
Each person whose signature appears below constitutes and appoints Miles D. White and Jose M. de Lasa, Esq., and each of them, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this registration statement, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
| Signature |
Title |
Date |
||
|---|---|---|---|---|
| /s/ MILES D. WHITE Miles D. White |
Chairman of the Board, Chief Executive Officer, and Director |
September 29, 2003 | ||
/s/ RICHARD A. GONZALEZ Richard A. Gonzalez |
President, Chief Operating Officer, Medical Products Group, and Director |
September 29, 2003 |
||
/s/ JEFFREY M. LEIDEN Jeffrey M. Leiden, M.D., Ph.D. |
President, Chief Operating Officer, Pharmaceutical Products Group, and Director |
September 29, 2003 |
||
/s/ THOMAS C. FREYMAN Thomas C. Freyman |
Senior Vice President, Finance and Chief Financial Officer (Principal Financial Officer) |
September 29, 2003 |
||
/s/ GREG W. LINDER Greg W. Linder |
Vice President and Controller (Principal Accounting Officer) |
September 29, 2003 |
||
/s/ ROXANNE S. AUSTIN Roxanne S. Austin |
Director |
September 29, 2003 |
||
S-3
/s/ H. LAURANCE FULLER H. Laurance Fuller |
Director |
September 29, 2003 |
||
/s/ JACK M. GREENBERG Jack M. Greenberg |
Director |
September 29, 2003 |
||
/s/ DAVID A. L. OWEN David A. L. Owen |
Director |
September 29, 2003 |
||
/s/ BOONE POWELL, JR. Boone Powell, Jr. |
Director |
September 29, 2003 |
||
/s/ A. BARRY RAND A. Barry Rand |
Director |
September 29, 2003 |
||
/s/ W. ANN REYNOLDS W. Ann Reynolds |
Director |
September 29, 2003 |
||
/s/ ROY S. ROBERTS Roy S. Roberts |
Director |
September 29, 2003 |
||
/s/ WILLIAM D. SMITHBURG William D. Smithburg |
Director |
September 29, 2003 |
||
/s/ JOHN R. WALTER John R. Walter |
Director |
September 29, 2003 |
S-4
| Exhibit No. |
Description |
|
|---|---|---|
| 5 | Opinion of Jose M. de Lasa. | |
23.1 |
The consent of counsel, Jose M. de Lasa, is included in his opinion. |
|
23.2 |
Consent of Deloitte & Touche LLP. |
|
23.3 |
Consent of Deloitte & Touche LLP. |
|
24 |
Power of Attorney is included on the signature page. |
|
99.1 |
Statement Regarding Consent of Arthur Andersen LLP. |
S-5